Skip to main content
Ch. 20 - Recombinant DNA Technology
Chapter 19, Problem 4

One of the major causes of sickness, death, and economic loss in the cattle industry is Mannheimia haemolytica, which causes bovine pasteurellosis, or shipping fever. Noninvasive delivery of a vaccine using transgenic plants expressing immunogens would reduce labor costs and trauma to livestock. An early step toward developing an edible vaccine is to determine whether an injected version of an antigen (usually a derivative of the pathogen) is capable of stimulating the development of antibodies in a test organism. The following table assesses the ability of a transgenic portion of a toxin (Lkt) of M. haemolytica to stimulate development of specific antibodies in rabbits. Immunogen Injected Antibody Production in Serum Lkt50*—saline extract + Lkt50*—column extract + Mock injection - *Lkt50 is a smaller derivative of Lkt that lacks all hydrophobic regions. indicates at least 50 percent neutralization of toxicity of Lkt; indicates no neutralization activity. Source: Modified from Lee et al. (2001). Infect. and Immunity 69:5786–5793. With regards to development of a usable edible vaccine, what work remains to be done?

Verified step by step guidance
1
Identify the effectiveness of the injected antigen in stimulating antibody production, as shown by the positive results in the table for Lkt50 extracts.
Determine if the transgenic plant can express the Lkt50 antigen effectively, ensuring it maintains its immunogenic properties when consumed.
Conduct trials to assess the immune response in cattle when the transgenic plant is used as an edible vaccine, ensuring it stimulates antibody production similar to the injected version.
Evaluate the safety and stability of the transgenic plant expressing Lkt50, ensuring it does not cause adverse effects in cattle.
Develop a scalable and cost-effective method for producing the transgenic plants, ensuring they can be distributed and used widely in the cattle industry.

Verified Solution

Video duration:
2m
This video solution was recommended by our tutors as helpful for the problem above.
Was this helpful?

Key Concepts

Here are the essential concepts you must grasp in order to answer the question correctly.

Transgenic Plants

Transgenic plants are genetically modified organisms that have had a foreign gene inserted into their genome. This technology allows for the expression of specific proteins, such as immunogens, which can be used in vaccine development. In the context of edible vaccines, transgenic plants can produce antigens that stimulate an immune response when consumed, potentially simplifying vaccine delivery and reducing costs.
Recommended video:
Guided course
02:56
Plant Gamete Terminology

Antibody Production

Antibody production is a crucial aspect of the immune response, where B cells produce antibodies in response to antigens. The presence of specific antibodies in serum indicates that the immune system has recognized and responded to a pathogen or its derivative. In the context of the question, assessing whether the injected antigen stimulates antibody production in test organisms is essential for evaluating the effectiveness of potential vaccines.
Recommended video:

Edible Vaccines

Edible vaccines are a novel approach to immunization that involves delivering antigens through food, typically produced in transgenic plants. This method aims to elicit an immune response without the need for injections, making vaccination more accessible and less traumatic for livestock. However, challenges remain in ensuring that these vaccines are effective, stable, and capable of inducing a strong immune response in the target organisms.
Recommended video:
Guided course
08:34
Cancer Causes
Related Practice
Textbook Question

What roles do restriction enzymes, vectors, and host cells play in recombinant DNA studies? What role does DNA ligase perform in a DNA cloning experiment? How does the action of DNA ligase differ from the function of restriction enzymes?

326
views
Textbook Question

The human insulin gene contains a number of sequences that are removed in the processing of the mRNA transcript. In spite of the fact that bacterial cells cannot excise these sequences from mRNA transcripts, explain how a gene like this can be cloned into a bacterial cell and produce insulin.

468
views
Textbook Question
One of the major causes of sickness, death, and economic loss in the cattle industry is Mannheimia haemolytica, which causes bovine pasteurellosis, or shipping fever. Noninvasive delivery of a vaccine using transgenic plants expressing immunogens would reduce labor costs and trauma to livestock. An early step toward developing an edible vaccine is to determine whether an injected version of an antigen (usually a derivative of the pathogen) is capable of stimulating the development of antibodies in a test organism. The following table assesses the ability of a transgenic portion of a toxin (Lkt) of M. haemolytica to stimulate development of specific antibodies in rabbits. Immunogen Injected Antibody Production in Serum Lkt50*—saline extract + Lkt50*—column extract + Mock injection - *Lkt50 is a smaller derivative of Lkt that lacks all hydrophobic regions. indicates at least 50 percent neutralization of toxicity of Lkt; indicates no neutralization activity. Source: Modified from Lee et al. (2001). Infect. and Immunity 69:5786–5793. What general conclusion can you draw from the data?
317
views
Textbook Question

Although many cloning applications involve introducing recombinant DNA into bacterial host cells, many other cell types are also used as hosts for recombinant DNA. Why?

303
views
Textbook Question

Using DNA sequencing on a cloned DNA segment, you recover the nucleotide sequence shown below. Does this segment contain a palindromic recognition sequence for a restriction enzyme? If so, what is the double-stranded sequence of the palindrome, and what enzyme would cut at this sequence? (Consult Figure 20.1 for a list of restriction sites.)

CAGTATGGATCCCAT

330
views
Textbook Question

As genetic testing becomes widespread, medical records will contain the results of such testing. Who should have access to this information? Should employers, potential employers, or insurance companies be allowed to have this information? Would you favor or oppose having the government establish and maintain a central database containing the results of individuals' genome scans?

227
views